MicroRNAs (miRNAs) are small, non-coding RNAs that regulate gene expression at the post-transcriptional level. Emerging evidence suggests that differential miRNA expression is associated with viral infection and cancer. Marek's disease virus infection induces lymphoma in chickens. However, the host defense response against Marek's disease (MD) progression remains poorly understood. Here, we utilized microarrays to screen miRNAs that were sensitive to Marek's disease virus (MDV) infection. QRT-PCR analysis confirmed the microarray data and revealed expression patterns of some miRNAs in tumor samples. Chicken miRNA gga-miR-15b, which was reduced in infected susceptible chickens and splenic tumors, controlled the expression of ATF2 (activating transcription factor 2). ATF2 was significantly increased in the same group. Our results indicated that differential expression of miRNA in resistant and susceptible chickens was caused by MDV infection, which effectively influenced protein expression of ATF2. This latter result might be related to Marek's disease resistance/susceptibility.
Introduction
MicroRNAs (miRNAs) are a class of small single-stranded, noncoding RNAs (~22 nt in length) that govern post-transcriptional repression of target genes by binding to 3′ untranslated regions (3′ UTRs) or gene bodies [13] . It has been shown that miRNAs are involved in a broad range of biological processes, including development, metabolism and cell differentiation [11, 13] . MiRNAs have been specifically implicated in tumorigenesis and pathogen infection [11, 19] . Functional evaluations of differentially expressed miRNAs have uncovered their abilities to elicit diverse immune responses, mainly through the regulation of immune cell differentiation and their association with immunity and inflammation [2, 19, 22] .
Marek's disease (MD) is chicken lymphoma caused by Marek's disease virus 1 (MDV1), which is an α-herpesvirus that is closely related to human herpesvirus 1 (herpes simplex virus type 1, HSV-1) and human herpesvirus 3 (varicella-zoster virus, VZV) [24] . MDV infection exhibits an early cytolytic phase between 3 and 7 days post infection (dpi) and then enters into the latent phase within 2 weeks. During this period, the MDV genome is maintained in host cells without the production of infectious progeny viruses [24] . Reactivation of MDV to the late cytolytic phase occurs between 14 and 21 dpi in MD susceptible chickens, which coincides with permanent immunosuppression [8, 24] . Here, we analyzed miRNA expression profiles in MD-resistant and MD-susceptible chickens to elucidate the function of miRNA in the regulation of Marek's disease (MD) resistance.
To date, 499 predicted and confirmed chicken miRNAs as well as 14 MDV-1 miRNAs have been released from miRBase (http:// miRNA.sanger.ac.uk/sequences/). A portion of chicken miRNAs was repressed in MDV-infected chicken embryo fibroblast cells [7] and displayed dynamic expression patterns during the development of chicken immune organs [14] . Several MDV-1 miRNAs, including MDV1-M2, MDV1-M3 and MDV1-M5 have been physically mapped to the regions flanking the MDV oncogene Meq [6] . However, the differences in miRNA expression between MD-resistant and MDsusceptible chickens, especially before and after MDV infection, are still unknown. These variations appear to be important for understanding host-virus interactions. In this study, we used two highly inbred chicken lines (line 6 3 and line 7 2 ) to evaluate the hypothesis that MDV infection induces distinct miRNA expression signatures in MDresistant and MD-susceptible chickens that modulate target gene expression. MDV can enter target cells in line 6 3 and line 7 2 chickens, but line 6 3 chickens survive after infection and most of them do not develop tumors. In contrast, line 7 2 is susceptible to MD, which leads to the development of lymphoma. Using this model, we identified 64 candidate miRNAs that were differentially expressed in the spleens of MDV-infected and noninfected line 7 2 chickens. Among these miRNAs, gga-miR-15b deregulation in infected line 7 2 was shown to control the expression of activating transcription factor 2 (ATF2), which was increased in infected line 7 2 chickens. Collectively, our data demonstrated that MDV infection caused distinct miRNA expression patterns in MD resistant and MD susceptible chickens, which effectively influence the protein levels of target gene in the infected samples. Taken together, these results provide clues for future exploration of how miRNAs are regulated in viral-induced tumors in vivo.
Materials and methods

Experimental animals and sample preparation
Line 6 3 and line 7 2 (USDA-ARS Avian Disease and Oncology Laboratory, East Lansing, Michigan, USA) are two highly inbred lines of specific-pathogen-free white leghorn chickens that are resistant and susceptible, respectively, to MD tumors. Chickens from each line were separated into two groups. One group was infected with a very virulent (vv+) strain of MDV (648A passage 40) at day 5 after hatching, while the other group did not receive MDV. Four chickens were selected from each group at 5, 10 and 21 days post infection (dpi), and none of them developed tumors during the experiment period. Besides the infected spleen samples from line 6 3 and line 7 2 , we received 4 spleen tumor samples of MDV infected chickens and 4 spleen samples of uninfected control birds from Avian Disease and Oncology Laboratory (ADOL, USDA). The tumor diagnosis and tumor sample collection were done by the veterinary medical officer in ADOL. Fresh spleen samples were harvested individually and stored in RNAlater solution (QIAGEN) at −80°C for DNA or RNA extraction. The entire animal experiment was conducted following the procedures and guidelines described in the "Guidelines for Animal Care and Use" manual approved by the Animal Care and Use Committee, the USDA-ARS, and the Avian Disease and Oncology Laboratory (Approval ID 111-26).
Quantification of MDV genome DNA loads in spleen samples
As previously described [1] , the MDV oncogene Meq was used to quantify viral genomic DNA at 5, 10 and 21 dpi. Quantitative PCR of the viral copy number was performed on genomic DNA (100 ng/μl) with the iCycler iQ PCR system (Bio-Rad, USA) and QuantiTect SYBR Green PCR Kit (Qiagen, USA). Relative MDV loads were determined after normalization to a single-copy gene VIM (vimentin) [33] .
MiRNA array profiling and data analysis
Total RNA was extracted from three spleen samples using the miRNeasy Mini Kit (QIAGEN). Total RNA quality was verified with Agilent 2100 Bioanalyzer chips (Agilent, Santa Clara, CA, USA). Three of the samples from each of the treatment groups from two chicken lines were processed for miRNA microarray analysis. Total RNA (1 μg) from each of the samples and the common reference sample were labeled with Hy3™ and Hy5™ fluorescent label, respectively, using the miRCURY™ LNA Array power labeling kit (Exiqon, Denmark) following the manufacturer's specifications. The Hy3™-labeled samples and a Hy5™-labeled reference RNA sample were mixed pair-wise and hybridized to the miRCURY™ LNA array (Version 9.2; Exiqon, Denmark), which contained capture probes targeting all of the miRNAs for all the species registered in the miRBASE (Version 10.1) at the Sanger Institute. One hundred and sixty-two of these probes were chicken-related miRNAs. Hybridization was performed according to the miRCURY™ LNA array manual with a Tecan HS4800 hybridization station (Tecan, Austria). After hybridization, the microarray slides were scanned and stored in an ozone free environment (ozone level below 2.0 ppb) to prevent potential bleaching of the fluorescent dyes. The miRCURY™ LNA array microarray slides were scanned using the Agilent G2565BA Microarray Scanner System (Agilent Technologies, Inc., USA) and image analysis was performed with ImaGene 8.0 software (BioDiscovery, Inc., USA). Microarray data were analyzed in R using the Limma package [29, 30] . Quantified signals within arrays were averaged and normalized using the global LOWESS (LOcally WEighted Scatterplot Smoothing) regression algorithm. Contrasts were made to compare noninfected and infected groups in both lines. Differentially expressed miRNAs were selected to perform cluster analysis with CLUSTER/TreeView software [10] . The target genes for miRNAs were predicted by RNA22 (http:// cbcsrv.watson.ibm.com/rna22.html).
2.4. Quantification of miRNA and mRNA levels using real-time PCR MiRNAs and mRNAs were extracted from four chicken spleen samples per treatment group using the miRNeasy Mini Kit (QIAGEN) and RNeasy Mini Kit (QIAGEN) according to the standard protocol by manufacturer including the on-column DNase digestion, respectively. MiRNA samples were reverse transcribed and quantified with a miScript Reverse Transcription Kit (QIAGEN), a miScript SYBR Green PCR Kit (QIAGEN), and 11 miScript Primer assays (QIAGEN). Reverse transcription and quantification of mRNA were performed with SuperScript™ III Reverse Transcriptase (Invitrogen) with oligo (dT) [12] [13] [14] [15] [16] [17] [18] primers (Invitrogen), and the QuantiTect SYBR Green PCR Kit. In the reverse transcription control, PCR water (Invitrogen) was used to replace miRNA or RNA samples. Briefly, 1 μg of purified miRNA or total RNA was used for reverse transcription, respectively, and 2 μl of RT products (1:5 dilution) were used for real-time PCR quantification. Two types of controls were applied in real-time PCR, including reverse transcription control and blank using PCR water. No amplicon was observed in the controls. The forward and reverse primers for ATF2 and Meq quantification are listed in Table 1 . A final volume of 20 μl real-time PCR product was incubated in an iCycler iQ PCR System (Bio-Rad), and each was performed on four biological replicates from the treatment per line in each experiment. Three independent experiments were carried out for each gene and miRNA. U6 or GAPDH (glyceraldehyde-3-phosphate dehydrogenase) was used as normalization control for the data [32] . After normalization, ANOVA and Tukey test were used to compare the miRNAs or genes expression levels (SAS version 9.2).
Western blot
Total protein was extracted by lysis of~20 mg of tissues with RIPA buffer (150 mM sodium chloride, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS and 50 mM Tris, pH 8.0) containing a protease inhibitor cocktail (Sigma). Approximately 20 mg of splenic tissue was homogenized in RIPA buffer, and the lysate was incubated at 4°C for 2 h with constant agitation and subsequently centrifuged at 4°C for 30 min. Protein concentration for each sample was determined by the BCA assay (Thermo Scientific). For the Western blotting, 30 μg of extracted protein was heated at 95-100°C for 5 min and loaded on 10% SDS-PAGE for electrophoresis. After separation, proteins were transferred onto polyvinylidene fluoride (PVDF) membrane and blocked with 5% nonfat milk in TBST containing 0.1% Tween 20. Primary antibodies (Santa Cruz) against ATF2 and β-actin were prepared at 1:500 and 1:1000 dilutions in TBST, respectively. Membranes were incubated with primary antibodies overnight at 4°C. Membranes were washed quickly 3 times (less than 1 min) and 3 more times for 5 min. Membranes were then incubated with anti-rabbit IgG and anti-mouse IgG secondary antibodies (Santa Cruz) diluted in TBST (1:5000) for 1 h at room temperature. The membranes were quickly washed 3 times and then washed 3 more times for 5 min each. Membranes were developed with ECL (Amersham) and measured using ChemiDoc XRS (Bio-Rad). Four independent experiments were done for each antibody.
Cell culture, plasmid constructs, transfection and luciferase reporter assay
Hela cells were grown in Dulbecco's modified Eagle's medium supplemented with 10%, fetal bovine serum, streptomycin (100 mg/ ml) and penicillin (100 U/ml) (Invitrogen). Cells were maintained at 37°C in humidified 5% CO 2 conditions. ATF2 cDNA fragments containing miRNA target sequences were amplified by PCR (primers in Table  S1 ), and cloned into pmirGLO Dual-Luciferase miRNA target expression vector (Promega) to create plasmid constructs. For transfection, cells were plated in 24-well plates and were~25% confluent 24 h before transfection. Before transfection, the medium was replaced with growth medium without antibiotics. Chicken miRNA mimics (QIAGEN) were diluted to working concentration(3 pmol/μl), and were co-transfected with plasmids (500 ng) harboring miRNA target sites using Lipofectamine 2000 transfection reagent (Invitrogen), and the medium was replaced with normal growth medium 4-6 h later. Cells were harvested after 24 h, and Renilla and firefly luciferase activities were measured using Dual-Luciferase Reporter Assay System (Promega).
Results
MiRNA expression profiles
Based on our criterion (p-value less than 0.05 and false discovery rate (FDR) smaller than 0.1), 64 out of the 162 miRNAs had significant differential expression between infected and noninfected line 7 2 chickens at 21 dpi, including the downregulation of 58 miRNAs and the upregulation of 6 miRNAs in the infected line 7 2 group (Tables 2a, 2b) . Notably, using the same criteria, none of the miRNAs were expressed differently between the infected and noninfected line 6 3 chickens (Table 2a) . Sixty-two miRNAs were expressed differently when infected line 6 3 and line 7 2 chickens were compared, including 50 downregulated and 12 upregulated miRNAs in the infected line 7 2 group (Tables 2a, 2c ). In total, 73 miRNAs showed differential expression. By using the cluster analysis that included all of the significantly expressed miRNAs, we found that the experimental birds were categorized into two groups (Fig. 1) . The infected line 7 2 birds were in one subgroup. In the other subgroup, noninfected line 7 2 chickens were associated with the line 6 3 chickens that were both infected and noninfected, indicating that their microRNA profiles were less varied (Fig. 2) . Additionally, we also found that the abundance of 10 MDV1 miRNAs dramatically increased in infected line 7 2 chickens but not in infected line 6 3 birds (Table 2d) . Based on the results from the microarray analysis and the potential functions of selected miRNAs, 3 (gga-miR-15b, gga-miR-456 and gga-let-7i miRNAs) were chosen to verify the results from the microarray analysis. The expressions of gga-miR-15b, gga-miR-456 and ggalet-7i were all significantly downregulated in infected line 7 2 samples compared to MDV-free chickens (p b 0.05) (Fig. 2a) . Significantly reduced expressions of gga-miR-456 and gga-let-7i were observed in infected line 7 2 chickens compared to infected line 6 3 chickens (p b 0.01 and p b 0.05 respectively). Transcription of gga-miR-15b was decreased in infected line 7 2 samples relative to infected line 6 3 samples, although this difference was not statistically significant (Fig. 2a) . These 3 miRNAs did not show significant variance between infected and noninfected in line 6 3 samples. Additionally, these 3 miRNAs were also repressed in splenic MD tumors compared to healthy spleen (p b 0.05), which was consistent with the microarray results (Fig. 2b) . Besides chicken miRNAs, the expression levels of MDV-miR-M2 and MDV-miR-M5 were significantly higher in the infected line 7 2 birds than in infected line 6 3 chickens (p b 0.01) (Fig. 3) . 
MiRNA Target Identification
To further understand the potential functions of miRNAs in MDV resistance and susceptibility, we examined the protein and mRNA levels of several genes that were reported to interact with MDV oncogene Meq. The protein level of activating transcription factor 2 (ATF2) was significantly increased in infected line 7 2 chickens compared to MDV-free chickens, whereas its expression was stable in line 6 3 birds before and after MDV challenge (Fig. 4a) . Comparably, qRT-PCR revealed that the mRNA levels of ATF2 were slightly decreased upon MDV infection in the two lines but were not significantly different (Fig. 4b) , indicating that miRNAs might be regulating ATF2 expression. By using a bioinformatic tool (RNAhybrid), 3 chicken miRNAs (gga-miR-15b, gga-miR-456 and gga-let-7i) were found to be among those differentially expressed and predicted to interact with ATF2 mRNA in its coding regions (Fig. 4c) . The speculation that ATF2 translational regulation requires chicken miRNAs was verified by the observation that induction of gga-miR-15b inhibited luciferase activity by~20% compared to negative control (p b 0.05) (Fig. 4d) . However, the presence of gga-let-7i silenced firefly luciferase activity by~15% although this difference was not statistically significant. We also found that gga-miR-456 did not influence the translation activity of the ATF2 (Fig. 4d) .
Discussion
MDV successfully infected chickens from line 6 3 and line 7 2 , but this infection had discordant behavior in the two lines. By measuring the copies of two important viral genes (Meq and ICP40), virus copy number was estimated and was similar between infected line 6 3 and infected line 7 2 chickens at 5 dpi, but was much higher in infected line 7 2 chickens than in infected line 6 3 chickens at 10 and 21 dpi (Fig.  S1 ). MDV has been reported to be relatively faster in line 7 2 than in line 6 3 [16, 26] . This phenomenon may be caused by the differential expression of microRNAs or may lead to the distinct microRNA expression in these two lines; however, this requires further investigation. The highest virus copy number was found at 21 dpi in both lines, and virus induced or repressed microRNAs could be detected at this time point. Compared to high-throughput RNA sequencing, microarray relies on the prior sequence information for probe designs, and focuses only on the well-studied miRNAs which were printed on the array, therefore, inadequate to identify novel miRNAs. Despite these limitations, array based approach is a feasible and cost-efficient method, and is expected to identify differentially expressed miRNAs in vivo. Therefore, to generate a global view of differentially expressed microRNAs, microarray analysis was conducted on samples at 21 dpi.
The spleen is an important immune organ that provides a niche for MDV to reach its primary targets (B cells and CD4 + T cells) during infection [24] . Because of the absence of classical transforming genes in MDV, the environment provided by the spleen is critical for viral replication [5] . Moreover, previous researches have already documented tissue-specific microRNA expression and methylation in different species [5, 18, 23, 31] . Therefore, all the experiments were carried out using splenic samples. To gain insights into MDV-induced microRNA expression variations in the immune system, this study profiled microRNA expression in resistant and susceptible chickens in vivo, which will improve our knowledge of the MDV-chicken interaction. Variation in miRNA expression induced by MDV infection has been identified in chicken embryo fibroblast (CEF), including some miRNAs that also showed differential expression in our study [7] . Based on the current microarray cutoff for differential expression (p b 0.05 and FDR b 0.1) in the microarray, miRNA expression was only significantly different between infected and noninfected line 7 2 groups, and between the infected line 6 3 and line 7 2 groups. This finding suggests that potential functions of these miRNAs were related to MD resistance and susceptibility. However, we did observe significant miRNAs between line 6 3 infected and uninfected chickens or between line 6 3 and line 7 2 with p b 0.05, but none of these miRNAs were confirmed by qRT-PCR. Because microRNA expression signature following MDV infection in line 6 3 and line 7 2 has not been studied, we compared our results with cDNA microarray analysis in the two lines. Previous studies examined gene expression in peripheral blood lymphocytes (PBLs) in two chicken lines and revealed that the expression of some genes showed at least two-fold changes between infected line 6 3 and line 7 2 chickens, while the transcriptional profiles of uninfected birds were similar, which agreed with our findings [21] . Collectively, our results demonstrated that differential expression of miRNAs was driven by MDV infection in line 6 3 and line 7 2 . Results from qRT-PCR were consistent with the microarray analysis for both cellular and viral miRNAs. These data demonstrated significant inactivation of cellular miRNA production and the increased MDV miRNA transcription in infected line 7 2 at 21 dpi. Moreover, we found a set of miRNAs (gga-miR-15, gga-miR-456 and gga-let-7i) that were deregulated in MD tumors, similar to infected line 7 2 , which implied their potential roles as tumor suppressors and early indicators of MD progression. However, other miRNAs had different transcriptional levels between tumor samples and infected line 7 2 (data not shown), suggesting different functions in viral infection and tumorigenesis. In contrast to cellular miRNAs, all of the MDV miRNAs were significantly upregulated. For example, MDV1-miR-M2 and MDV1-miR-M5, located at the 5′ upstream of Meq [6] , were overexpressed in the infected line 7 2 at 21 dpi compared to the infected line 6 3 . This result is consistent with the higher DNA copy number and activated transcription of Meq (Figs. S1 and S2), and highlighted increased viral replication in infected line 7 2 .
The candidate target genes regulated by differentially expressed miRNAs were predicted using bioinformatic tools miRDB and MDV MicroRNA Target Prediction (Supplementary Tables 1 and 2 ). The pathway analysis was done using IPA (Ingenuity systems pathway analysis) to further clarify the molecular functions that miRNAs may be involved in (Supplementary Table 3 ). Several immune related pathways, such as NF-κB signaling and T cell and B cell receptor signaling were included, implying that miRNAs may influence MD resistance or susceptibility through controlling the immune responses. The discovery of the miRNA gga-miR-15b target, ATF2, is valuable for understanding the etiology of MD. ATF2 is a sequence-based DNA binding protein that belongs to the cAMP-response element (CRE)-binding protein (CREB) family, which regulates proliferation and apoptosis by altering downstream gene expression [25] . The mRNA level of ATF2 was only slightly reduced (20% and 10%, respectively) after MDV infection in line 6 3 and line 7 2 , suggesting MDV infection did not modulate ATF2 transcription. In line 7 2 chickens, after MDV infection, ATF2 protein increased significantly compared to noninfected birds. Interestingly, in the same line, the increase of ATF2 was coincident with the decrease of gga-miR-15b level. Bioinformatics analysis predicted that ATF2 was one of the direct targets for gga-miR15b. The luciferase reporter assay showed that gga-miR-15b indeed depressed ATF2. This information suggested that in line 7 2 , MDV infection resulted in the downregulation of gga-miR-15b thus released its inhibition on ATF2 translation. The coexpression of ATF2 and ggamiR-15b was observed in line 6 3 . Traditionally, it is believed that because of its inhibition effect, miRNA and its target show a mutually exclusive pattern. However, this classic view has been disputed by recent publications that show miRNA and its target can be coexistent to maintain the balance of translational network [12, 20, 27, 28] . It appeared that the abundance of ATF2 protein was similar in line 6 3 chickens regardless of MDV infection; however, this observation was not surprising because it was well possible that in this resistant line, some unknown mechanisms prevent MDV from reducing ggamiR-15b expression to increase ATF2 translation. The mechanisms that inhibit MDV-mediated reduction of gga-miR-15b in line 6 3 remained unclear. The distinct genetic backgrounds, such as SNPs and gene expression variations between two lines may contribute to the different regulatory mechanisms. The unique expression pattern and distinctive regulatory mechanism may suggest that ATF2 plays different roles in line 7 2 and line 6 3 . As far as the biological function of ATF2 is concerned, several lines of evidence suggest that ATF2 may work as an oncogene or tumor suppressor dependent on the cellular systems. For example, it has been reported that ATF2 elicited tumor suppressor or oncogene activities in different cancers by cooperation with other tumor suppressors or oncogenes [3, 4, 15] . Chicken ATF2 was documented to form a heterodimer with c-Jun, MDV oncogene Meq and other b-ZIP proteins [15, 17, 24] . In line 7 2 , we found the ATF2 protein level was higher in MDV infected birds than uninfected chickens. Since MDV oncogene Meq was highly expressed in line 7 2 after MDV infection, ATF2 probably formed a heterodimer with Meq and favor MD development. In the line 6 3 , due to the absence of Meq after MDV exposure, ATF2 may be in cooperation with c-Jun and perform distinct functions as in line 7 2 . Considering the dramatic difference in Meq expression between infected line 7 2 and infected line 6 3 , it is likely that ATF2 may have different partners and play distinct roles in two chicken lines after MDV infection even though the expression was similar between infected line 7 2 and infected line 6 3 . The other chicken miRNA gga-let-7i, which was also deregulated in line 7 2 after MDV challenge, may have negative effects on ATF2 translation since it slightly suppressed luciferase activities, but might not control ATF2 translation alone. In general, miRNA regulation of gene expression is largely dependent on binding at the 3′ UTR. However, miRNA target sites in the coding regions of genes have recently been reported in humans [9] . The validation that ggamiR-15b reduced ATF2 expression provided further evidence that the miRNA regulation of gene expression could depend on the binding at the coding region.
In summary, MDV challenge in resistant and susceptible chicken lines resulted in differential miRNA expression signatures in the spleens of infected chickens. The expression of most cellular miRNAs was dramatically decreased, but viral miRNAs were overexpressed in the MDV-infected susceptible line. In contrast, chicken miRNA transcription was relatively stable while MDV miRNA expression was suppressed in infected resistant lines. The repression of miRNA results in distinct target gene expression in the two lines after MDV infection. ATF2 was identified as a direct target for gga-miR-15b, and the biological consequences of ATF2 on MD resistance and susceptibility in vivo should be further elucidated.
Supplementary materials related to this article can be found online at doi:10.1016/j.ygeno.2011.11.004.
